Canadian researchers have evaluated the capabilities of two artificial intelligence chatbots, Google Gemini and Bard, in the ophthalmology board examination.
Breaking News
Regeneron Faces Lawsuit for Misreporting Eylea Prices to MedicareApr 15, 2024The U.S. Department of Justice (DOJ) has initiated a lawsuit against Regeneron Pharmaceuticals under the False Claims Act (FCA), accusing the biotechnology company of fraudulently inflating Medicare reimbursement rates.
Glaukos Receives Permanent J-Code for iDose TRApr 04, 2024Glaukos has announced the assignment of a unique, permanent J-code (J7355) by CMS for its iDose TR (travoprost intracameral implant) 75 mcg.
Caplin Granted USFDA Approval for Ketoralac Tromethamine Ophthalmic SolutionApr 16, 2024Caplin Steriles Limited (Caplin), a subsidiary of Caplin Point Laboratories Limited, has received final approval from the USFDA for its Abbreviated New Drug Application (ANDA) for Ketorolac Tromethamine Ophthalmic Solution 0.5%.
Ophthalmic Research News
Blinking Enhances Visual Signal Strength, New Study FindsApr 17, 2024Researchers at the University of Rochester have discovered a new benefit of blinking—it enhances visual signal strength, in addition to its known role of keeping the eyes moist.
The Serious Impact of Smoking on Your Eye Health Mar 25, 2024Smoking is widely recognized as a major health hazard, contributing to a range of systemic diseases, including lung cancer, heart disease, stroke as well as eye diseases.